-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics FY 2024 GAAP EPS CHF (0.05) Down From CHF (0.03) YoY, Sales CHF 404.102K Down From CHF 1.612M YoY

Benzinga·04/25/2025 05:34:58
Listen to the news

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of CHF (0.05) per share. This is a 66.67 percent decrease over losses of CHF (0.03) per share from the same period last year. The company reported CHF 404.102 thousand in sales this quarter. This is a 74.93 percent decrease over sales of CHF 1.612 million the same period last year.